Storia in 2 fonti

Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Alkem Laboratories promoters sold a 1.5% stake for Rs 930 crore. Promoter holding fell below 50% as mutual funds and global investors bought shares.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 g fa

Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Alkem promoters sell 1.5% stake (Rs 930 crore) to Goldman Sachs, ICICI Prudential and institutional buyers, dropping below 50% control. Shift from family to global institutions opens M&A window; signals mid-cap pharma consolidation in India.

originale

economictimes.indiatimes.com18 h fa

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Alkem Laboratories launched semaglutide pre-filled syringes (India first) at Rs 350, securing DCGI approval for diabetes and obesity treatment. A Rs 930-crore institutional block deal led by ICICI Prudential and Goldman Sachs signals sustained investor confidence in established pharma amid volatility.

Timeline cronologica

martedì 2 giugno 2026·economictimes.indiatimes.com
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of domestic mutual funds and foreign…
martedì 2 giugno 2026·thehindubusinessline.com
Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%
Alkem Laboratories promoters sold a 1.5% stake for Rs 930 crore. Promoter holding fell below 50% as mutual funds and global investors bought shares.

Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Timeline cronologica

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale